SS 0111
Alternative Names: SS-0111Latest Information Update: 22 Jul 2022
At a glance
- Originator Ariceum Therapeutics
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Small cell lung cancer; Solid tumours
Most Recent Events
- 21 Jul 2022 Preclinical trials in Small cell lung cancer in Germany (IV) (Ariceum Therapeutics pipeline, July 2022)
- 21 Jul 2022 Preclinical trials in Solid tumours in Germany (IV) (Ariceum Therapeutics pipeline, July 2022)